In the realm of breast cancer treatment, taxane-based chemotherapy stands as a cornerstone for managing early-stage disease, offering hope to countless patients. However, this potent therapy often comes with a significant drawback: chemotherapy-induced peripheral neuropathy (CIPN), a condition
In an era where medical advancements are reshaping how humanity approaches health, a transformative idea is gaining traction among scientists who argue that the key to tackling chronic diseases lies not in treating them individually, but in targeting the very biology of aging itself. This
What happens when the joy of motherhood is eclipsed by an unyielding fog of despair for nearly half a million women in the U.S. each year? Postpartum depression (PPD), a debilitating condition affecting about 15% of new mothers, often turns a time of bonding into a battle for mental survival. Amid
What happens when a rare cancer keeps coming back, defying every treatment thrown at it? For adults battling relapsed marginal zone lymphoma (MZL), a subtype of non-Hodgkin lymphoma, this relentless cycle has long been a harsh reality, but a flicker of hope emerges as Bristol Myers Squibb’s
Imagine a cellular mechanism so fundamental to life that it not only kickstarts DNA replication but also holds the reins of gene expression, dictating which genetic instructions are read or silenced in human cells. The origin-recognition complex (ORC), long understood as the spark for DNA copying,
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development has positioned him at the forefront of innovation in cancer treatment. With a deep understanding of cutting-edge technologies, Ivan has been exploring groundbreaking
